Clinical Trials on Transplants and Implants in Peru
Total 1960 results
-
PfizerCompletedPain | Sprains and Strains | SprainChile, Mexico, Argentina, Colombia, Peru
-
AO GENERIUMRecruitingST Elevation Myocardial InfarctionRussian Federation
-
Institut de cancérologie Strasbourg EuropeUniversity of Oslo; Oslo University Hospital; University of Bristol; Heidelberg... and other collaboratorsRecruitingGallbladder Cancer | Gallstone DiseaseChile, France, Argentina, Bolivia, Peru
-
AbbVie (prior sponsor, Abbott)Fundasamin (Argentina)CompletedRespiratory Syncytial Virus InfectionArgentina, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
-
Unity Health TorontoOntario Ministry of Health and Long Term Care; Heart and Stroke Foundation... and other collaboratorsCompletedIschemic StrokeThailand, Canada, Argentina, Brazil, Peru
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedCervical CancerUnited States, Australia, Peru, Puerto Rico
-
NovartisCompletedHypertensionUnited States, Belgium, Canada, Germany, Italy, Netherlands, Peru, Russian Federation, Switzerland, United Kingdom
-
AstraZenecaCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Brazil, Colombia, Peru
-
BioFire Defense LLCNational Institute of Allergy and Infectious Diseases (NIAID); United States...Active, not recruitingFeverUnited States, Uganda, Thailand, Tanzania, Cambodia, Georgia, Ghana, Honduras, Kenya, Peru
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia (PHN) | Chemotherapy Induced Neuropathic Pain | Diabetic Peripheral Neuropathic Pain (DPN) | HIV-related Neuropathic Pain (HIV)Colombia, Mexico, Ecuador, Peru, Venezuela
-
IgenomixCompletedInfertility | Aneuploidy | Chromosome AbnormalityMexico, Turkey, United States, Argentina, Spain, Brazil, Italy, Peru
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug ResistantKorea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
-
SPP Pharmaclon Ltd.RecruitingRespiratory TuberculosisRussian Federation
-
McMaster UniversityChinese University of Hong Kong; Hamilton Health Sciences Corporation; Prince... and other collaboratorsCompletedCovert Postoperative StrokeCanada, Malaysia, United States, New Zealand, Chile, Hong Kong, India, Peru, Poland
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, France, Peru, South Africa, Thailand
-
GlaxoSmithKlineMedicines for Malaria VentureCompletedMalaria, VivaxThailand, India, Brazil, Ethiopia, Peru, Bangladesh, Cambodia, Philippines
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Ovarian Cancer | Metastatic Cancer | Melanoma (Skin)United States, Australia, Peru, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Cryptococcal MeningitisKenya, Thailand, Uganda, United States, Peru, South Africa, Zimbabwe, India
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisRussian Federation
-
National Institute of Allergy and Infectious Diseases...Bill and Melinda Gates FoundationCompletedHIV InfectionsUnited States, Brazil, Ecuador, Peru, South Africa, Thailand
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionPeru, Kenya, Malawi, Brazil, South Africa, Zimbabwe, India, Thailand, Tanzania
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
Partners in HealthHarvard Medical School (HMS and HSDM); Epicentre; Interactive Research and Development and other collaboratorsCompletedTuberculosis, Multidrug-ResistantGeorgia, Armenia, Bangladesh, Belarus, Ethiopia, Indonesia, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Myanmar, Pakistan, Peru, South Africa
-
Hoffmann-La RocheCompletedAnemiaMexico, Colombia, Argentina, Venezuela, Brazil, Uruguay, Ecuador, Peru, Chile
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | OsteoporosisFrance, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
-
GlaxoSmithKlineCompletedImpetigoIndia, Mexico, Netherlands, Italy, Peru
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States, Australia, Peru, Puerto Rico
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Janssen Infectious Diseases BVBACompletedTuberculosisSouth Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
-
Novartis PharmaceuticalsCompletedThrombocytopaeniaBelgium, Greece, Netherlands, Romania, China, Korea, Republic of, Tunisia, France, Hong Kong, Ireland, Peru, Poland
-
Berlin-Chemie AG Menarini GroupCompletedDeep Vein ThrombosisGeorgia, Russian Federation
-
AbbVieCompletedChronic Hepatitis C (CHC)Russian Federation
-
NeuromaxBioneviaCompletedDiabetic Peripheral NeuropathyRussian Federation
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
GlaxoSmithKlineCompletedNeoplasms, BreastFrance, Belgium, Peru, Italy, Colombia
-
Fulcrum TherapeuticsTerminated
-
NPO PetrovaxCompletedFibrosis | Lung Diseases, Interstitial | Lung; Disease, Interstitial, With Fibrosis | Post-Acute COVID-19 Syndrome | Lung Disease With PolymyositisRussian Federation
-
Materia Medica HoldingCompletedInfluenza and Acute Respiratory Viral InfectionsRussian Federation, Belarus, Ukraine
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultidrug-resistant TuberculosisSouth Africa, Estonia, Philippines, Peru, Lithuania, Latvia, Moldova, Republic of
-
International Atomic Energy AgencyCompletedCervix CancerPeru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom
-
Materia Medica HoldingCompletedAcute Respiratory Viral InfectionRussian Federation
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, Puerto Rico
-
AstraZenecaRecruitingNon-small-cell Lung CancerRussian Federation
-
UCB PharmaTerminatedRheumatoid Arthritis | Crohn's DiseaseRussian Federation